Nalphin Injection 10 mg/ml contains Nalbuphine, a semi-synthetic opioid analgesic used for the management of moderate to severe pain. It is commonly administered in hospital settings via intravenous (IV), intramuscular (IM), or subcutaneous (SC) injection to provide rapid and effective pain relief. Unlike pure opioid agonists, Nalbuphine is a mixed agonist-antagonist, offering analgesic benefits with a lower risk of certain opioid-related side effects such as respiratory depression.
Nalbuphine works by binding to kappa-opioid receptors in the central nervous system, producing analgesia, while acting as a partial antagonist at mu-opioid receptors. This mechanism allows effective pain control while reducing the likelihood of euphoria and addiction commonly associated with other opioids. Nalphin provides quick onset of pain relief, making it suitable for post-operative pain, labor pain, and other acute pain conditions.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Nalphin Injection 10 mg/ml is indicated for:
Management of moderate to severe acute pain, including post-operative pain
Relief of pain during labor and delivery
Analgesia for patients requiring parenteral opioid therapy in hospital settings
It is particularly useful in situations where rapid and reliable pain relief is required and oral administration is not feasible.
The dosage of Nalphin Injection depends on the severity of pain, the patient’s response, and the route of administration:
Adults: The usual dose is 10–20 mg IV, IM, or SC every 3–6 hours as required. The injection should be administered slowly when given intravenously to minimize adverse effects.
Elderly or debilitated patients: Dose adjustment may be necessary based on individual tolerance and medical condition.
It is important to titrate the dose carefully to achieve adequate pain relief while minimizing potential side effects. Healthcare professionals should monitor patients closely for signs of over-sedation or other adverse reactions.
Use cautiously in patients with respiratory disorders, such as asthma or chronic obstructive pulmonary disease, as opioids may cause respiratory depression.
Avoid use in patients with head injuries, increased intracranial pressure, or impaired consciousness.
Caution is advised in patients with liver or kidney impairment; dose adjustment may be required.
Nalphin may interact with other CNS depressants, alcohol, or sedatives, enhancing sedative or respiratory effects.
Not recommended during pregnancy unless clearly necessary and under medical supervision.
Patients should be monitored for dependence or abuse potential, though Nalbuphine carries a lower risk than pure mu-opioid agonists.
Nalphin Injection 10 mg/ml is generally well tolerated when used appropriately. Common side effects may include:
Drowsiness or sedation
Dizziness
Nausea and vomiting
Sweating
Headache
Less commonly, patients may experience hypotension, bradycardia, or respiratory depression. Severe allergic reactions, though rare, require immediate medical attention.
Store below 30°C in a cool, dry place, protected from light. Keep out of reach of children.
Nalphin Injection 10 mg/ml provides effective and rapid pain relief for moderate to severe pain in clinical settings. Its mixed agonist-antagonist profile ensures strong analgesia with a reduced risk of respiratory depression and abuse, making it a valuable option for acute pain management.
Login Or Registerto submit your questions to seller
No none asked to seller yet